Sporadic pancreatic insulinomas (PIs) are challenging lesions with low oncologic risk but a high symptom burden. Despite their low malignant risk, the debilitating symptoms of
AE
AE
EUS-RFA Is Highly Effective in the Treatment of Sporadic Pancreatic Insulinomas With Fewer Adverse Events Compared to Surgery
EUS-RFA Is Highly Effective in the Treatment of Sporadic Pancreatic Insulinomas With Fewer Adverse Events Compared to Surgery
